TrialPath
Recruiting

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

NCT07589608 · Eli Lilly and Company
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
A Phase 2b, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight and Without Type 2 Diabetes
About this study
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to examine the body weight-lowering efficacy and safety of macupatide plus eloralintide compared with placebo in participants with obesity or overweight and without type 2 diabetes. Participation will last about 64 weeks.
Eligibility criteria
Inclusion Criteria: * See Master Protocol CWMM (NCT06143956) for inclusion criteria Exclusion Criteria: In addition to exclusion criteria in Master Protocol CWMM (NCT06143956): * Have type 1 diabetes or type 2 diabetes * Have an ongoing history of bradyarrhythmia and/or sinus bradycardia * Have an elevated resting pulse rate (greater than 100 bpm) or reduced resting pulse rate (less than 60 bpm) * Have a history of acute or chronic pancreatitis * All concomitant medications should be at a stable dose for at least 3 months prior to screening
Study design
Enrollment target: 400 participants
Allocation: randomized
Masking: double
Age groups: adult, older_adult
Timeline
Starts: 2026-05-15
Estimated completion: 2028-02
Last updated: 2026-06-24
Interventions
Drug: MacupatideDrug: EloralintideDrug: Placebo
Primary outcomes
  • Percent Change from Baseline in Body Weight (Baseline, Week 36)
Sponsor
Eli Lilly and Company · industry
Contacts & investigators
ContactTrial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · contact · LillyTrials@Lilly.com · 317-615-4559
ContactPhysicians interested in becoming principal investigators please contact · contact · clinical_inquiry_hub@lilly.com
InvestigatorCall 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST) · study_director, Eli Lilly and Company
All locations (40)
The Institute for Liver Health II dba Arizona Clinical Trials - MesaRecruiting
Chandler, Arizona, United States
Headlands Research - ScottsdaleRecruiting
Scottsdale, Arizona, United States
The Institute for Liver Health II dba Arizona Liver Health-TucsonRecruiting
Tucson, Arizona, United States
NorCal Medical Research, IncRecruiting
Greenbrae, California, United States
Velocity Clinical Research, Huntington ParkRecruiting
Huntington Park, California, United States
Peninsula Research AssociatesRecruiting
Rolling Hills Estates, California, United States
Diablo Clinical Research, Inc.Recruiting
Walnut Creek, California, United States
Stamford Therapeutics ConsortiumRecruiting
Stamford, Connecticut, United States
New Horizon Research CenterRecruiting
Miami, Florida, United States
Indago Research & Health Center, IncRecruiting
Miami Lakes, Florida, United States
Suncoast Clinical Research, Inc.Recruiting
New Port Richey, Florida, United States
Charter Research - Winter ParkRecruiting
Orlando, Florida, United States
Charter Research - Lady LakeRecruiting
The Villages, Florida, United States
Medical Research PartnersRecruiting
Ammon, Idaho, United States
Great Lakes Clinical Trials - RavenswoodRecruiting
Chicago, Illinois, United States
Cotton O'Neil Diabetes & EndocrinologyRecruiting
Topeka, Kansas, United States
Monroe Biomedical Research - LouisvilleRecruiting
Louisville, Kentucky, United States
KnownwellRecruiting
Needham, Massachusetts, United States
Lucida Clinical TrialsRecruiting
New Bedford, Massachusetts, United States
Headlands Research - DetroitRecruiting
Southfield, Michigan, United States
Arcturus Healthcare , PLC, Troy Internal Medicine Research DivisionRecruiting
Troy, Michigan, United States
StudyMetrix ResearchRecruiting
City of Saint Peters, Missouri, United States
Clinvest Headlands LlcRecruiting
Springfield, Missouri, United States
Las Vegas Medical ResearchRecruiting
Las Vegas, Nevada, United States
Dent Neurologic InstituteRecruiting
Amherst, New York, United States
Rochester Clinical Research, LLCRecruiting
Rochester, New York, United States
Medication ManagementRecruiting
Greensboro, North Carolina, United States
Monroe Biomedical ResearchRecruiting
Monroe, North Carolina, United States
Lucas Research, IncRecruiting
Morehead City, North Carolina, United States
Lucas Research, Inc.Recruiting
New Bern, North Carolina, United States
CTI Clinical Research CenterRecruiting
Cincinnati, Ohio, United States
Tribe Clinical Research, LLCRecruiting
Greenville, South Carolina, United States
Quality Medical ResearchRecruiting
Nashville, Tennessee, United States
IMA Clinical Research AustinRecruiting
Austin, Texas, United States
FutureSearch Trials of DallasRecruiting
Dallas, Texas, United States
PlanIt Research, PLLCRecruiting
Houston, Texas, United States
Endeavor Clinical TrialsRecruiting
San Antonio, Texas, United States
Texas Valley Clinical ResearchRecruiting
Weslaco, Texas, United States
Sovah Clinical Research-River DistrictRecruiting
Danville, Virginia, United States
Central Washington Health Services Association d/b/a Confluence HealthRecruiting
Wenatchee, Washington, United States
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · TrialPath